At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

Calling for “systemic change,” former Alaska Congresswoman Mary Peltola announced on January 12 that she will run for the U.S ...

In California, the birthplace of much of the world’s technology innovation, virtual reality is being used in an unexpected ...

Pune: Two scientists from Dr DY Patil University in Pimpri won the Indian Council of Medical Research (ICMR) ...

Senate modernized its payment system and appointed a new attorney general at its first meeting of winter quarter.

A Sacramento Bee review of over 100 campaign accounts reveals how lawmakers use their war chests to shore up connections and ...

The collaboration builds on the internal strengths of Bayer in antibody design, synthesis and machine learning, complementing with Cradle's deep expertise in scalable software development. Bayer and ...

Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to ...

In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...

A public hearing drew in hundreds to the Roland E. Powell Convention center on Monday night, as eight local leaders and ...

Crofelemer has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) and the European Medicines ...

About the FALCON Trial FALCON is a first-in-human, open-label, multi-center Phase 1b clinical trial designed to evaluate the safety and tolerability of SGT-212 in participants aged 18-40 who have been ...